Genomics meets immunity in pancreatic cancer: Current research and future directions for pancreatic adenocarcinoma immunotherapy

Pancreatic adenocarcinoma (PDAC) remains a formidable disease that needs improved therapeutic strategies. Even though immunotherapy has revolutionized treatment for various solid tumor types, it remains largely ineffective in treating individuals with PDAC. This review describes how the application...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Rev
Main Authors: Bowers, Jacob S., Bailey, Stefanie R., Rubinstein, Mark P., Paulos, Chrystal M., Camp, E. Ramsay
Formato: Artigo
Idioma:Inglês
Publicado: PAGEPress Publications, Pavia, Italy 2019
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6686121/
https://ncbi.nlm.nih.gov/pubmed/31456872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/oncol.2019.430
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares